Table 1. Clinical characters and outcomes for the patients with advanced heart failure and/or cardiogenic shock underwent Impella implantation.
| Particulars | N = 10 |
|---|---|
| Age, y, mean ± SD | 69.7 ± 9 |
| Gender, male, n (%) | 6 (60) |
| Presentation, n (%) | |
| STEMI, n (%) | 1 (10) |
| NSTEMI, n (%) | 6 (60) |
| Cardiac arrest post–CPR, n (%) | 3 (30) |
| LVEF, %, mean ± SD (range) | 14.7 ± 9.8 (5–30%) |
| EuroScore, mean ± SD (range) | 40 ± 12.9 (29–65) |
| Hemodynamic parameters | |
| PASP, mm Hg, mean ± SD (range) | 64.5 ± 9.7 (50–79) |
| Cardiac index, L/(min × m2), mean (range) | 2.1 (1.3–2.6) |
| PCWP, mm Hg, mean ± SD (range) | 31 ± 7.7(13–40) |
| Duration of Impella support, range | 2 h–8 d |
| Successful PCI, mean (%) | 10 (100) |
| Complications | |
| Limb ischemia requiring amputation, mean (%) | 1 (10) |
| Anemia requiring transfusion, mean (%) | 2 (20) |
| Outcome | |
| Good recovery, mean (%) | 8 (80) |
| Bridge to LVAD, mean (%) | 1 (10) |
| Death within 30 days, mean (%) | 2 (20) |
Abbreviations: LVAD, left ventricle assisting device; N, number of patients; NSTEMI, non-ST elevated myocardial infarction; PASP, pulmonary artery systolic pressure; PCI, percutaneous coronary intervention; PCWP, pulmonary capillary wedge pressure; SD, standard deviation; STEMI, ST elevated myocardial infarction; y, year.